First Eagle Investment Management
MRVI icon

First Eagle Investment Management’s Maravai LifeSciences MRVI Stock Holding History

First Eagle Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.14M Buy
2,524,336
+725,000
+40% +$2.46M 0.01% 234
2025
Q4 		$5.85M Buy
1,799,336
+1,348,405
+299% +$4.54M 0.01% 240
2025
Q3 		$1.29M Buy
+450,931
New +$1.15M ﹤0.01% 325

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management's MRVI Position: Q1 2026 in Review

First Eagle Investment Management increased its Maravai LifeSciences (MRVI) stake by 40% in Q1 2026, buying an estimated $2.46M and bringing the position to 2,524,336 shares worth $7.14M. The position accounts for 0.01% of the portfolio, ranked #234.

First Eagle Investment Management first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • First Eagle Investment Management held 2,524,336 shares of Maravai LifeSciences worth $7.14M as of Q1 2026.
  • First Eagle Investment Management bought 725,000 Maravai LifeSciences shares in Q1 2026, an estimated $2.46M.
  • Maravai LifeSciences made up 0.01% of First Eagle Investment Management's portfolio in Q1 2026, its #234 holding.
  • First Eagle Investment Management first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.